Aktie A3C3DQ LEVITEE LABS INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Levitee Labs Inc.

Aktien

A3C3DQ

CA5274241051

LVT

Markt geschlossen - Canadian Securities Exchange
Andere Börsenplätze
 17:03:02 01.02.2023 		% 5 Tage % 1. Jan.
0.005 CAD -.--% Intraday Chart für Levitee Labs Inc. -.--% -.--%
2022 Levitee Labs Inc. kündigt Änderungen in der Geschäftsführung an CI
2022 Levitee Labs Inc. kündigt CEO-Wechsel an CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
IIROC Trading Halt - LVT
Levitee Labs Inc. Announces Executive Changes
Levitee Labs Inc. Announces CEO Changes
Levitee Labs Announces Philip Van Den Berg to Join as Interim CEO and the Board of Directors and Close First Tranche of Private Placement for $1.5 Million
Levitee Labs Inc. Announces Philip Van Den Berg to Join as Interim CEO
Levitee Labs Inc. Announces Philip Van Den Berg to Join the Board of Directors
Levitee Labs Announces Non-Brokered Private Placement of up to $3,000,000
Levitee Labs Inc. announced that it expects to receive CAD 3 million in funding
Levitee Labs Signs Retail Distribution Agreement with Body Energy Club for MONKE Nutraceuticals
Levitee Labs Inc Signs Retail Distribution Agreement with Body Energy Club for MONKE Nutraceuticals
Levitee Labs Partners with Canntab Therapeutics to Provide Alternatives to Opioids
Levitee Labs Inc. Enters into A Strategic Partnership Via A Services Agreement with Canntab Therapeutics Limited
CORRECTION - Levitee Labs Announces Medical Advisory Board
Levitee Labs Inc. Appoints Maigul Wickham as its Chief Financial Officer Replacing Mason Darabi
Levitee Labs Announces Medical Advisory Board
Levitee Labs Announces Medical Advisory Board
Levitee Labs Announces Strategic Partnership with LiveRx Research Group to Provide Equitable Access to Hepatitis C Care throughout Alberta, Canada
Levitee Labs Inc. Announces Strategic Partnership with LiveRx Research Group to Provide Equitable Access to Hepatitis C Care Throughout Alberta, Canada
Levitee Labs Appoints Noha ElSayed as Executive Director for Levitee Clinics and Levitee Pharmacies in the Alberta Region
Levitee Labs Inc. Appoints Noha ElSayed as Executive Director for Levitee Clinics and Levitee Pharmacies in the Alberta Region
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A3C3DQ Aktie
  4. Nachrichten Levitee Labs Inc.
  5. Andere Sprachen